Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium
- PMID: 23091408
- PMCID: PMC3477680
- DOI: 10.7150/ijms.4843
Gross total resection of glioma with the intraoperative fluorescence-guidance of fluorescein sodium
Abstract
Objective: High dose fluorescein sodium has been utilized for fluorescence-guided tumor resection with conflicting reports on the efficacy of this procedure. The aim of this study was to reevaluate the utility and clinical limitations of using fluorescein sodium for the treatment and resection of glioma brain tumors.
Methods: Patients diagnosed with glioma were divided into two groups with a total of 22 patients enrolled in the study: 1) the study group (n=10), patients that received intravenous injection of fluorescein sodium and 2) the control group (n=12), patients that did not receive injections during surgical resection. Quality of life was evaluated according to Karnofsky Performance Scale (KPS) score and neurological status. Fluorescein sodium was intravenously injected at a dose of 15-20mg/kg of body weight. Glioma resection was evaluated preoperative and postoperatively with enhanced Magnetic Resonance Imaging (MRI).
Results: Significant differences in the gross total resection (GTR) rates were observed between the two patient groups (Fisher's Exact Test p=0.047). Progressive free survival was significantly longer in the study group (Student's T-Test p=0.033) as well as in the GTR group (Student's T-Test p=0.0001) compared to the control and non-GTR groups, respectively. Three patients in the study group and four patients in the control group had transient neurological deterioration. One patient in the control group had permanent hemiplegia.
Conclusion: The intraoperative utility of using fluorescein sodium can significantly increase the GTR rate without obvious deterioration. In addition, we find that it is better to apply the fluorescein sodium in the cases with BBB (blood-brain barrier) disruption, which had been enhanced in preoperative MRI.
Keywords: fluorescein sodium; glioma; gross-total resection; neurosurgery.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures


Similar articles
-
Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.J Neurosurg. 2017 Jul;127(1):111-122. doi: 10.3171/2016.7.JNS16232. Epub 2016 Oct 7. J Neurosurg. 2017. PMID: 27715437
-
Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.J Neurosurg. 2015 Jun;122(6):1360-9. doi: 10.3171/2015.2.JNS132507. Epub 2015 Apr 3. J Neurosurg. 2015. PMID: 25839919
-
Fluorescein-Guided Surgery for High-Grade Glioma Resection: An Intraoperative "Contrast-Enhancer".World Neurosurg. 2017 Aug;104:239-247. doi: 10.1016/j.wneu.2017.05.022. Epub 2017 May 13. World Neurosurg. 2017. PMID: 28512039
-
Fluorescein-Guided Resection of High Grade Gliomas: A Meta-Analysis.World Neurosurg. 2021 Nov;155:181-188.e7. doi: 10.1016/j.wneu.2021.08.126. Epub 2021 Sep 4. World Neurosurg. 2021. PMID: 34492388 Review.
-
Sodium fluorescein guided resection of malignant glioma.J Pak Med Assoc. 2018 Jun;68(6):968-970. J Pak Med Assoc. 2018. PMID: 30323373 Review.
Cited by
-
5-aminolevulinic acid, fluorescein sodium, and indocyanine green for glioma margin detection: analysis of operating wide-field and confocal microscopy in glioma models of various grades.Front Oncol. 2023 May 23;13:1156812. doi: 10.3389/fonc.2023.1156812. eCollection 2023. Front Oncol. 2023. PMID: 37287908 Free PMC article.
-
Emerging Therapies for Glioblastoma.Cancers (Basel). 2024 Apr 12;16(8):1485. doi: 10.3390/cancers16081485. Cancers (Basel). 2024. PMID: 38672566 Free PMC article. Review.
-
Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection.Neurosurgery. 2021 Oct 13;89(5):727-736. doi: 10.1093/neuros/nyaa475. Neurosurgery. 2021. PMID: 33289518 Free PMC article. Review.
-
Label-Free Neurosurgical Pathology with Stimulated Raman Imaging.Cancer Res. 2016 Jun 15;76(12):3451-62. doi: 10.1158/0008-5472.CAN-16-0270. Epub 2016 Apr 12. Cancer Res. 2016. PMID: 27197198 Free PMC article.
-
Fluorescein-guided resection of newly diagnosed high-grade glioma: Impact on extent of resection and outcome.Brain Spine. 2022 Nov 9;2:101690. doi: 10.1016/j.bas.2022.101690. eCollection 2022. Brain Spine. 2022. PMID: 36506293 Free PMC article.
References
-
- Babu R, Adamson C. Fluorescence-Guided Malignant Glioma Resections. Curr Drug Discov Technol. 2012 [Epub ahead of print] - PubMed
-
- Shinoda J, Sakai N, Murase S. et al. Selection of eligible patients with supratentorial glioblastoma multiforme for gross total resection. J Neurooncol. 2001;52:161–71. - PubMed
-
- Stummer W, Reulen HJ, Meinel T. et al. Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery. 2008;62:564–76. - PubMed
-
- Tykocki T, Michalik R, Bonicki W. et al. Fluorescence-guided resection of primary and recurrent malignant gliomas with 5-aminolevulinic acid. Preliminary results. Neurol Neurochir Pol. 2012;46:47–51. - PubMed
-
- Koc K, Anik I, Cabuk B. et al. Fluorescein sodium-guided surgery in glioblastoma multiforme: a prospective evaluation. Br J Neurosurg. 2008;22:99–103. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical